April 2009
Volume 50, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2009
Na+/H+- Exchanger-1 Inhibition Counteracts Diabetes-Induced Cataractogenesis and Retinal Oxidative Stress and Apoptosis
Author Affiliations & Notes
  • I. G. Obrosova
    Pennington Biomedical Research Center, Louisiana State University, Baton Rouge, Louisiana
  • V. R. Drel
    Pennington Biomedical Research Center, Louisiana State University, Baton Rouge, Louisiana
  • J. Shin
    Pennington Biomedical Research Center, Louisiana State University, Baton Rouge, Louisiana
  • B. A. Pillai
    College of Pharmacy, University of Georgia, Augusta, Georgia
  • U. A. Julius
    Medical Clinic III, University Hospital, Dresden, Germany
  • A. B. El-Remessy
    College of Pharmacy, University of Georgia, Augusta, Georgia
  • Footnotes
    Commercial Relationships  I.G. Obrosova, None; V.R. Drel, None; J. Shin, None; B.A. Pillai, None; U.A. Julius, None; A.B. El-Remessy, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 5358. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      I. G. Obrosova, V. R. Drel, J. Shin, B. A. Pillai, U. A. Julius, A. B. El-Remessy; Na+/H+- Exchanger-1 Inhibition Counteracts Diabetes-Induced Cataractogenesis and Retinal Oxidative Stress and Apoptosis. Invest. Ophthalmol. Vis. Sci. 2009;50(13):5358.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Na+-H+-exchanger-1 (NHE-1) controls intracellular pH and glycolytic enzyme activities, and its expression and activity are increased by diabetes and high glucose. Upregulation of the upper part of glycolysis under conditions of inhibition (lens) or insufficient activation (retina) of glyceraldehyde 3-phosphate dehydrogenase underlies diversion of excessive glycolytic flux towards several pathways contributing to oxidative stress, a causative factor in diabetic cataractogenesis and retinopathy. We evaluated the role for NHE-1 in diabetic cataract formation and retinal oxidative stress and apoptosis.

Methods: : Mature control and STZ-diabetic rats were treated with/without the NHE-1 inhibitor cariporide (C, Sanofi-Aventis, 10 mgkg-1d-1) for 3.5 mo. Lens clarity was evaluated by indirect ophthalmoscopy and slit lamp examination on a weekly basis. A by-product of glycolysis, -glycerophosphate (GP), was measured in the lens and retina by enzymatic spectrofluorometric assay. Cell death was assessed in flat-mounted retinas by TUNEL immunoperoxidase staining. In in vitro studies, bovine retinal pericytes and endothelial cells were cultured in 5 or 30 mM glucose, with or without 10 µM C, for 7 days. Nitrotyrosine (NT), poly(ADP-ribose), and TUNEL-positivity were assessed by fluorescent immunocytochemistry.

Results: : A several-fold increase of GP, indicative of activation of the upper part of glycolysis, was present in both rat lens and retina at early (1-1.5 mo) stage of STZ-diabetes. C treatment delayed, but did not prevent, diabetic cataractogenesis. The number of TUNEL positive cells was increased 4.4-fold in diabetic rats compared with controls (101 ± 17 vs 23 ± 8 per retina, p < 0.01), and this increase was attenuated, but not completely prevented, by C (45 ± 12, p < 0.01 vs untreated diabetic group). Nitrotyrosine and poly(ADP-ribose) fluorescence and percentage of TUNEL-positive cells were increased in pericytes and endothelial cells cultured in 30 mM glucose, vs those cultured in 5 mM glucose. Nitrosative stress, poly(ADP-ribose) accumulation, and cell death were completely or partially prevented by C.

Conclusions: : NHE-1 contributes to diabetic cataract formation, retinal oxidative-nitrosative stress, PARP activation, and premature cell death. The findings identify new therapeutic target and provide rationale for detailed evaluation of NHE-1 inhibitors on diabetic ocular complications.

Keywords: diabetic retinopathy • oxidation/oxidative or free radical damage • cataract 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×